Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy. 1997

R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.

BACKGROUND IgE titres tend to rise early after the start of immunotherapy, followed by a decline to pre-immunotherapy levels or lower. OBJECTIVE We were interested to know whether the early increase in IgE antibodies includes new specificities of IgE, and whether these responses persist. METHODS Sera of 64 patients undergoing grass pollen immunotherapy were tested for IgE against four purified grass pollen allergens: Lol p 1, 2, 3, and 5. At least two serum samples were taken, one before the start of therapy and one between 5 and 18 months after the first immunization (mean: 10 months). RESULTS The mean IgE responses to Lol p 1, 2 and 3 showed a moderate but not significant increase. In contrast, the mean IgE response to Lol p 5 showed a significant decrease of > 30%. IgE against total Lohum perenne pollen extract moderately increased (> 20%), showing that a RAST for total pollen is not always indicative for the development of IgE against its major allergens. For > 40% of the patients it was found that IgE against one or more of the four allergens increased, while IgE against the remaining allergen(s) decreased. For 10 sera the ratio of IgE titres against at least two allergens changed by at least a factor of 5. The changes in specific IgE also included conversions from negative (< 0.1 RU) to positive (0.6 to 5.0 RU) for five patients. For two patients, the induction of these 'new' IgE antibodies against major allergens was shown to result in a response that was persistent over several years. CONCLUSIONS Although active induction of new IgE specificities by immunotherapy was not really proven, the observations in this study indicate that monitoring of IgE against purified (major) allergens is necessary to evaluate changes in specific IgE in a reliable way.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008129 Lolium Common member of the Gramineae family used as cattle FODDER. It harbors several fungi and other parasites toxic to livestock and people and produces allergenic compounds, especially in its pollen. The most commonly seen varieties are L. perenne, L. multiflorum, and L. rigidum. Ryegrass,Rye Grass,Grass, Rye
D010940 Plant Proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available. Plant Protein,Protein, Plant,Proteins, Plant
D011058 Pollen The fertilizing element of plants that contains the male GAMETOPHYTES. Male Gametes, Plant,Male Gametophytes,Microspores, Plant,Plant Microspores,Pollen Grains,Gamete, Plant Male,Gametes, Plant Male,Gametophyte, Male,Gametophytes, Male,Grain, Pollen,Grains, Pollen,Male Gamete, Plant,Male Gametophyte,Microspore, Plant,Plant Male Gamete,Plant Male Gametes,Plant Microspore,Pollen Grain
D011852 Radioallergosorbent Test An in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IMMUNOGLOBULIN E antibodies. Radioimmunosorbent Assay of Allergens,Allergens Radioimmunosorbent Assay,Allergens Radioimmunosorbent Assays,Radioallergosorbent Tests,Test, Radioallergosorbent,Tests, Radioallergosorbent
D006255 Rhinitis, Allergic, Seasonal Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS. Hay Fever,Pollen Allergy,Pollinosis,Seasonal Allergic Rhinitis,Hayfever,Allergic Rhinitides, Seasonal,Allergic Rhinitis, Seasonal,Allergies, Pollen,Allergy, Pollen,Fever, Hay,Pollen Allergies,Pollinoses,Rhinitides, Seasonal Allergic,Rhinitis, Seasonal Allergic,Seasonal Allergic Rhinitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings

Related Publications

R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
December 2001, Allergy,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
December 2002, Allergy,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
February 1998, The Journal of allergy and clinical immunology,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
January 2002, European journal of immunology,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
April 1996, International archives of allergy and immunology,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
April 1998, Molecular immunology,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
August 1978, Allergy,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
April 1982, Allergy,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
March 1996, The Journal of allergy and clinical immunology,
R Van Ree, and W A Van Leeuwen, and P H Dieges, and R G Van Wijk, and N De Jong, and P Z Brewczyski, and A M Kroon, and P P Schilte, and K Y Tan, and I F Simon-Licht, and A M Roberts, and S O Stapel, and R C Aalberse
December 1987, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!